当前位置: X-MOL 学术Thorac. Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study.
Thoracic Cancer ( IF 2.3 ) Pub Date : 2020-05-28 , DOI: 10.1111/1759-7714.13490
Takaya Ikeda 1, 2 , Shinnosuke Takemoto 2 , Hiroaki Senju 3 , Hiroshi Gyotoku 2 , Hirokazu Taniguchi 2, 4 , Midori Shimada 2, 3 , Yosuke Dotsu 2 , Yasuhiro Umeyama 2 , Hiromi Tomono 3, 5 , Takeshi Kitazaki 6 , Masaaki Fukuda 6 , Hiroshi Soda 3 , Hiroyuki Yamaguchi 2 , Minoru Fukuda 2, 7 , Hiroshi Mukae 2
Affiliation  

The aim of this study was to assess the efficacy and safety of amrubicin for previously treated malignant pleural mesothelioma.

中文翻译:

先前治疗的恶性胸膜间皮瘤患者中的氨柔比星:II期研究。

这项研究的目的是评估氨柔比星对先前治疗的恶性胸膜间皮瘤的疗效和安全性。
更新日期:2020-05-28
down
wechat
bug